Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 88
Number of items: 88
  • Open Access
    Verstegen, N. J. M., Pollastro, S., Unger, P.-PA., Marsman, C., Elias, G., Jorritsma, T., Streutker, M., Bassler, K., Haendler, K., Rispens, T., Schultze, J. L., ten Brinke, A., Beyer, M., & van Ham, S. M. (2023). Single-cell analysis reveals dynamics of human B cell differentiation and identifies novel B and antibody-secreting cell intermediates. eLife, 12, Article e83578. https://doi.org/10.7554/elife.83578
  • Open Access
    Verstegen, N. J. M. C. (2023). Going beyond your form: T-cell dependent B-cell fate determination. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    van Osch, T. L. J., Steuten, J., Nouta, J., Koeleman, C. A. M., Bentlage, A. E. H., Heidt, S., Mulder, A., Voorberg, J., van Ham, S. M., Wuhrer, M., ten Brinke, A., & Vidarsson, G. (2023). Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophages. Platelets (London), 34(1), Article 2129604. https://doi.org/10.1080/09537104.2022.2129604
  • Open Access
    Steuten, J. (2023). Uncharted territories: Exploring the role of platelets, pO2 and atypical B cells in the regulation of immune balance. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    van Kempen, Z. L. E., Stalman, E. W., Steenhuis, M., Kummer, L. Y. L., van Dam, K. P. J., Wilbrink, M. F., Ten Brinke, A., van Ham, S. M., Kuijpers, T., Rispens, T., Eftimov, F., Wieske, L., Killestein, J., & T2B! immunity against SARS-CoV-2 study group (2023). SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(4), 280-283. https://doi.org/10.1136/jnnp-2022-330100
  • Open Access
    Koers, J. (2023). B cell and antibody differentiation: The contribution of glycans to repertoire diversification and classification. [Thesis, fully internal, Universiteit van Amsterdam].
  • Stalman, E. W., Tas, S. W., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases. Annals of the Rheumatic Diseases, 81(12), 1757-1766. https://doi.org/10.1136/ard-2022-222904
  • Boekel, L., Besten, Y. R., Hooijberg, F., Wartena, R., Steenhuis, M., Vogelzang, E., Leeuw, M., Atiqi, S., Tas, S. W., Lems, W. F., van Ham, S. M., Eftimov, F., Stalman, E. W., Wieske, L., Kuijpers, T. W., Voskuyl, A. E., van Vollenhoven, R. F., Gerritsen, M., Krieckaert, C., ... Wolbink, G. (2022). SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period. The Lancet. Rheumatology, 4(11), e747-e750. https://doi.org/10.1016/S2665-9913(22)00221-1
  • Boekel, L., Tas, S. W., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies. The Lancet. Rheumatology, 4(6), e417-e429. https://doi.org/10.1016/S2665-9913(22)00102-3
  • Wieske, L., Tas, S. W., Takkenberg, R. B., Verstegen, N. J. M., Zwinderman, K. A. H., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study. The Lancet. Rheumatology, 4(5), e338-e350. https://doi.org/10.1016/S2665-9913(22)00034-0
Page 4 of 9